Abstract
MicroRNAs (miRNAs) comprise a large group of small noncoding RNAs within a heterogeneous entity of noncoding RNAs, forming potent functional tools regulating the crucial biological processes within cells and the body. Cell-free miRNAs have become one of the novel promising diagnostic, predictive, and prognostic biomarkers for various diseases extensively investigated in recent years. This is due to their presence within extracellular fractions of various body fluids suggesting their potential as noninvasive “liquid biopsy” in case of their dysregulated expression.
Among the body fluids, blood plasma and serum along with urine are the most commonly investigated sources of various types of cell-free miRNAs. Another body fluid, i.e., ascites (effusion, peritoneal/pleural fluid) may be the clinically important fluid particularly associated with carcinogenesis in ovarian carcinomas and hepatocellular carcinomas or in case of liver cirrhosis.
Here, we provide a protocol for an expression profiling study based on qPCR analyses aimed at finding novel candidate miRNAs via small-scale or large-scale screening and evaluation experiments using liquid biopsies of blood plasma, ascites, and urine. Using this approach may be worth in cases where no (or limited) information is available on miRNA expression in particular diseases and geographic regions, for validation of previously published miRNAs with promising diagnostic potential, particularly in situations where follow-up study is aimed at validating miRNAs coming from (micro) array or NGS experiments, or where funding for large-scale experiments is not available. We demonstrate that assessment of plasma, ascites, and urine miRNAs expression may represent a feasible method to explore the potential for finding novel diagnostic, predictive, and prognostic biomarkers for various diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Weber JA, Baxter DH, Zhang SL et al (2010) The MicroRNA Spectrum in 12 body fluids. Clin Chem 56:1733–1741
Záveský L, Jandáková E, Weinberger V et al (2022) Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers. Mol Biol Rep 49(3):1955–1971
Záveský L, Jandáková E, Weinberger V et al (2019) Ascites-derived extracellular microRNAs as potential biomarkers for ovarian cancer. Reprod Sci 26(4):510–522
Záveský L, Jandáková E, Weinberger V et al (2019) Ovarian cancer: differentially expressed microRNAs in tumor tissue and cell-free Ascitic fluid as potential novel biomarkers. Cancer Investig 37(9):440–452
Záveský L, Jandáková E, Weinberger V et al (2022) Ascites in ovarian cancer: MicroRNA deregulations and their potential roles in ovarian carcinogenesis. Cancer Biomark 33(1):1–16
Záveský L, Jandáková E, Turyna R et al (2015) Evaluation of cell-free urine microRNAs expression for the use in diagnosis of ovarian and endometrial cancers. A pilot study. Pathol Oncol Res 21(4):1027–1035
Záveský L, Jandáková E, Turyna R et al (2016) Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers. Neoplasma 63(1):121–132
Vandesompele J, De Preter K, Pattyn F et al (2002) Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:research0034.1
Pfaffl MW, Tichopad A, Prgomet C, Neuvians TP (2004) Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – excel-based tool using pair-wise correlations. Biotechnol Lett 26:509–515
Andersen CL, Jensen JL, Ørntoft TF (2004) Normalization of realtime quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245–5250
Acknowledgements
This work was supported by the Cooperation Program, research area Oncology and Haematology (Charles University, Prague), MH CZ-DRO-VFN64165 (Ministry of Health of the Czech Republic), and a grant no. LTAUSA19049 (Ministry of Education, Youth and Sports of the Czech Republic). We would like to thank ČEPS, a.s., for their kind support of our research.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Záveský, L., Slanař, O. (2023). Discovery and Evaluation of Extracellular MicroRNA Biomarkers in Plasma, Ascites, and Urine. In: Dalmay, T. (eds) MicroRNA Detection and Target Identification. Methods in Molecular Biology, vol 2630. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2982-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2982-6_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2981-9
Online ISBN: 978-1-0716-2982-6
eBook Packages: Springer Protocols